Lilly Affinitac Launch Supply Will Be Produced By Isis; Deliveries Start In 2003
Executive Summary
Isis will begin building launch supply of the non-small cell lung cancer antisense drug Affinitac in early 2003 under a manufacturing agreement with Lilly announced Oct. 1